BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31196683)

  • 21. Vaccines for preventing influenza in people with asthma.
    Cates CJ; Rowe BH
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD000364. PubMed ID: 23450529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Cole KS; Martin JM; Horne WT; Lin CJ; Nowalk MP; Alcorn JF; Zimmerman RK
    Vaccine; 2017 Dec; 35(49 Pt B):6893-6897. PubMed ID: 29132989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost Effectiveness of Influenza Vaccine for U.S. Children: Live Attenuated and Inactivated Influenza Vaccine.
    Shim E; Brown ST; DePasse J; Nowalk MP; Raviotta JM; Smith KJ; Zimmerman RK
    Am J Prev Med; 2016 Sep; 51(3):309-17. PubMed ID: 27079638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination.
    Stockwell MS; Broder KR; Lewis P; Jakob K; Iqbal S; Fernandez N; Sharma D; Barrett A; LaRussa P
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e7-e14. PubMed ID: 27302328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A postlicensure evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 24-59 months of age.
    Toback SL; Ambrose CS; Eaton A; Hansen J; Aukes L; Lewis N; Wu X; Baxter R
    Vaccine; 2013 Apr; 31(14):1812-8. PubMed ID: 23395734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma.
    Turner PJ; Fleming L; Saglani S; Southern J; Andrews NJ; Miller E;
    J Allergy Clin Immunol; 2020 Apr; 145(4):1157-1164.e6. PubMed ID: 31863808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Influenza Vaccination Rates After Withdrawal of Live Vaccine.
    Robison SG; Dunn AG; Richards DL; Leman RF
    Pediatrics; 2017 Nov; 140(5):. PubMed ID: 28986441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine.
    Chung JR; Flannery B; Thompson MG; Gaglani M; Jackson ML; Monto AS; Nowalk MP; Talbot HK; Treanor JJ; Belongia EA; Murthy K; Jackson LA; Petrie JG; Zimmerman RK; Griffin MR; McLean HQ; Fry AM
    Pediatrics; 2016 Feb; 137(2):e20153279. PubMed ID: 26738884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study.
    Daley MF; Clarke CL; Glanz JM; Xu S; Hambidge SJ; Donahue JG; Nordin JD; Klein NP; Jacobsen SJ; Naleway AL; Jackson ML; Lee G; Duffy J; Weintraub E
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):59-68. PubMed ID: 29148124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL; Toback SL; Yi T; Ambrose CS
    Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016.
    Moro P; Baumblatt J; Lewis P; Cragan J; Tepper N; Cano M
    Drug Saf; 2017 Feb; 40(2):145-152. PubMed ID: 27988883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine for chronic obstructive pulmonary disease (COPD).
    Kopsaftis Z; Wood-Baker R; Poole P
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002733. PubMed ID: 29943802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Merckx J; McCormack D; Quach C
    Vaccine; 2016 Feb; 34(6):750-6. PubMed ID: 26752064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.
    Tennis P; Toback SL; Andrews E; McQuay LJ; Ambrose CS
    Vaccine; 2011 Jul; 29(31):4947-52. PubMed ID: 21596087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.
    Gaglani MJ; Piedra PA; Riggs M; Herschler G; Fewlass C; Glezen WP
    Pediatr Infect Dis J; 2008 May; 27(5):444-52. PubMed ID: 18401289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season.
    Kawai AT; Li L; Kulldorff M; Vellozzi C; Weintraub E; Baxter R; Belongia EA; Daley MF; Jacobsen SJ; Naleway A; Nordin JD; Lee GM
    Pharmacoepidemiol Drug Saf; 2014 May; 23(5):548-53. PubMed ID: 24497128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Ortiz JR; Goswami D; Lewis KD; Sharmeen AT; Ahmed M; Rahman M; Rahman MZ; Feser J; Neuzil KM; Brooks WA
    Vaccine; 2015 Jun; 33(29):3415-21. PubMed ID: 25917680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.